NasdaqGS:ALNYBiotechs
AI Collaboration Puts Alnylam’s RNAi Pipeline Productivity In Focus
Alnylam Pharmaceuticals (NasdaqGS:ALNY) has announced a new collaboration with AI firm Inceptive Nucleics focused on accelerating RNAi drug discovery.
The partnership will apply generative AI models to RNAi drug design with the goal of improving research productivity and speed for new therapeutics.
This AI collaboration is positioned as an important step in advancing Alnylam's Alnylam 2030 strategy.
For investors tracking Alnylam Pharmaceuticals at a share price of $292.58, this AI...